Trial NCT01066468

View at ClinicalTrials.gov 
Org. Study IDs: CSTI571A2110
Secondary IDs: 2010-018418-53

Last trial update was posted on 2012-03-13

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Hematologic Diseases Leukemia Leukemia, Lymphoid Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Chronic Myeloid Leukemia (CML) Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN) Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID